Track 1: Basic Science
Progress in Global TB control is seriously constrained by the lack of effective, new drugs, diagnostics and vaccines. This track will therefore focus on improving and expanding the understanding of basic science issues required for the development of new tools and advancing the knowledge base on mechanisms of TB infection and disease, host –pathogen interaction, immunology, genetics, and biomarkers, particularly through recent advances in genomics and molecular biology.
Track 2: Clinical, Epidemiological and Operational Research
Changes in policies for HIV-related TB, drug-resistant TB, and the implementation of new tools for TB control require comprehensive, evidence-based approaches and best-practice models within existing health systems and partnerships. This track will therefore focus on the latest findings from controlled clinical trials and research studies aimed at improving the epidemiological, programmatic, health systems and policy components of TB control.
Track 3: Patient and Civil Society Mobilisation and Advocacy
Ensuring optimal TB control requires political commitment through advocacy and civil society mobilization, fusing the complimentary fields of basic science, biomedical, epidemiological, qualitative and programmatic research with patient-driven civil society advocacy and resource mobilization. This track will therefore focus on achieving broad-based partnerships built on the principles of greater involvement of persons with TB, targeted advocacy, partnerships and the role of civil society in TB control and increasing access to TB diagnosis, treatment and adherence support service.